Part-Time

MRI Technologist

Updated on 7/21/2026

Akumin

Akumin

1,001-5,000 employees

Outsourced radiology and oncology services

No salary listed

Orlando, FL, USA + 11 more

More locations: New Port Richey, FL, USA | Dade City, FL, USA | Palm Harbor, FL, USA | Tampa, FL, USA | Largo, FL, USA | Punta Gorda, FL, USA | Brandon, FL, USA | Clearwater, FL, USA | Seminole, FL, USA | St. Petersburg, FL, USA | Sarasota, FL, USA

In Person

Local travel may be required; multiple Florida locations.

Category
Medical, Clinical & Veterinary (1)

Get referred to Akumin

Find people who can refer or advise you

Requirements
  • High School Diploma or equivalent experience required
  • State license, if applicable required
  • ARRT(MR) or ARMRIT certification as allowable by contract in lieu of ARRT
  • CPR Certification, BLS from the American Heart Association (AHA) or American Red Cross (ARC)
  • ACLS certification where applicable
  • Valid state driver’s license, as applicable required
  • Minimum 3 years technologist experience
  • Ability to work at several locations
  • Strong customer service skills
  • Organizational, multi-tasking, and critical thinking skills
  • Basic knowledge of computer applications and programs
  • Local travel may be required
  • The employee may be exposed to outside weather conditions during transport of patients if working on a mobile unit
  • The employee will be exposed to a strong magnetic field
  • May be exposed to blood/body fluids and infectious disease
Responsibilities
  • Be responsible for Patient Safety, including pre-screening for contra-indications, restricting patients, staff, and visitor access related to zones, screening, equipment, and exam scanning as deemed necessary and exercise individual thought, judgment and discretion in the performance of the procedure, aseptic injection technique and may require oversight of remote MRI Technologist Assistants.
  • Produces high quality diagnostic images in accordance with company imaging protocols, RadSite Accreditation guidelines, and ARRT/ARMRIT practice standards. Knowledge and ability to demonstrate competency of differing MR equipment and power injection equipment. Maintain levels of quality that meet or exceed customer expectations through process improvement and a team-oriented approach. Complete annual and on-going education and site specific competencies/in-services as designated by leadership.
  • Effectively communicates with customers and/or radiologists. Demonstrates the ability to use all channels of communications to address concerns, solve problems, and address conflict. Maintain confidentiality in matters relating to patients, family and staff in compliance with HIPAA.
  • Demonstrate independent competency in contrast safety and administration, including starting and discontinuing peripheral IV’s, and administration of contrast through other vascular access points such as ports, CVL’s and PICC lines if indicated. Demonstrate proficiency of Akumin’s EMR systems, as well as PACS and DICOM systems for image sharing and interpretation.
  • Train and orient new technologists, patient coordinators and MR Technologist Assistants, on site and/or through a remote command center as needed.
  • Other duties as assigned by leadership.
Desired Qualifications
  • 1 year of Magnetic Resonance Imaging Experience
  • Registry in Magnetic Resonance by the ARRT

Akumin provides outsourced radiology and oncology services to hospitals, health systems, and physician groups across the United States through a network of fixed-site outpatient imaging centers and outpatient radiology and oncology services. It operates imaging centers and partners with healthcare facilities to offer diagnostic imaging, interpretation, and related outpatient services at scale across 47 states. Its nationwide focus on outsourced radiology and oncology allows hospitals to access imaging and cancer-care resources without maintaining all services in-house. The company aims to be a trusted partner for healthcare providers by delivering reliable, scalable imaging and cancer-care services that improve patient access to diagnostics and treatment.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Plantation, Florida

Founded

1997

Get referred to Akumin

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Projected US imaging utilization in 2055 will be 16.9% to 26.9% higher than 2023, driven by population growth.
  • Akumin launched new relocatable imaging centers after emerging from Chapter 11 in February 2024, addressing rising demand.
  • Akumin and United Imaging announced a multi-year alliance to modernize facilities, enhancing operational efficiency and capacity.

What critics are saying

  • Stonepeak fully controls Akumin post-bankruptcy, blocking strategic pivots or competitor bids with 90-100% probability in 6-12 months.
  • Patients demanding $5M settlement for negligent data breach exposing health records have 80-95% probability in 0-6 months.
  • New mobile MRI from Drop Trailer directly competes with Akumin's relocatable AXIS clinics with 60-75% probability in 6-12 months.

What makes Akumin unique

  • Akumin uniquely produces relocatable AXIS clinics with pre-installed MRI, PET, or LINAC technology for high-volume deployment.
  • Akumin operates one of the nation's largest networks of fixed-site radiology centers and mobile solutions across the US.
  • Akumin partners with over 800 hospitals and physician groups, enabling rapid scaling of imaging and oncology services nationwide.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

31%

1 year growth

31%

2 year growth

31%
Innovate Healthcare
Jan 5th, 2026
Akumin secures $154M investment and restructures debt to extend repayment timeline to 2031

Akumin Inc. has secured $154 million in new capital from Stonepeak, an alternative investment firm, to support long-term growth of its imaging and radiation oncology services. The company is also restructuring its debt with noteholders representing over 95% of its outstanding senior secured notes. Under the agreement, Akumin's existing debt will be exchanged for new senior secured notes due in 2031, carrying a 9.75% interest rate that can drop to 8.75% if certain credit targets are met. The company's revolving credit facility, with roughly $119 million outstanding, will convert into preferred equity or move to a lower-priority position. The restructuring follows Akumin's recent launch of new offerings at the Radiological Society of North America meeting, including its Axis Drop Trailer and relocatable MRI suites.

Cantech Letter
Oct 23rd, 2023
Akumin likely won’t get a better offer than Stonepeak, Clarus says

The deal from private equity firm Stonepeak to acquire Akumin likely won’t be topped, says Clarus Securities analyst Noel Atkinson.

PR Newswire
Oct 20th, 2023
Akumin Inc. Reaches Agreement With Stonepeak To Become A Private Company

Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growthApprovals received from key stakeholders across capital structure; transaction will be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 daysBusiness will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary coursePLANTATION, Fla., Oct. 20, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success. The contemplated transaction will result in Akumin no longer being publicly listed.To effect the transaction in a timely and efficient manner, the Company and certain of its subsidiaries will commence prepackaged chapter 11 cases in the Southern District of Texas. The Company expects to obtain court approval of the transaction within the next 45 days and complete the transaction after receiving certain regulatory approvals. Throughout the process, Akumin's operations are expected to continue as normal